Head and neck tumor cell radiation response occurs in the presence of IGF1

Journal of Dental Research

Volumn 90, Issue 3, 2011, Pages 347-352

  Victory, K ^a   Burd, R ^a   Fribley, A ^b   Sittadjody, S ^a   Arnett, D ^a   Klein, R R ^c   Limesand, K H ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

head and neck cancer; IGF1; radiation

Indexed keywords

COBALT; RADIOPROTECTIVE AGENT; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANALYSIS OF VARIANCE; ANIMAL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CELL SURVIVAL; DRUG EFFECT; HEAD AND NECK TUMOR; HUMAN; MOUSE; NONPARAMETRIC TEST; NUDE MOUSE; RADIATION EXPOSURE; RADIATION INJURY; RADIOISOTOPE THERAPY; SALIVARY GLAND; SKULL IRRADIATION; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; TUMOR CELL LINE;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; COBALT RADIOISOTOPES; CRANIAL IRRADIATION; HEAD AND NECK NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOISOTOPE TELETHERAPY; RECEPTOR, IGF TYPE 1; SALIVARY GLANDS; STATISTICS, NONPARAMETRIC;

EID: 79952047093     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510388037     Document Type: Article

References (18)

1. Amornphimoltham P, Sriuranpong V, Patel V, Benavides F, Conti CJ, Sauk J, et al. (2004). Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 10(12 Pt 1):4029-4037. (Pubitemid 38812478)
2. Burd R, Wachsberger PR (2007). Application of radiotherapy and chemotherapy protocols to pre-clinical tumor models. Curr Protoc Pharmacol 38:14.7.1-14.7.24.
3. Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, et al. (2006). Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. Anticancer Res 26:1773-1784. (Pubitemid 43989431)
4. Choong NW, Cohen EE (2006). Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol 57:25-43. (Pubitemid 41804078)
5. Fribley AM, Evenchik B, Zeng Q, Park BK, Guan JY, Zhang H, et al. (2006). Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa. J Biol Chem 281:31440-31447. (Pubitemid 46041408)
6. Grundmann O, Mitchell GC, Limesand KH (2009). Sensitivity of salivary glands to radiation: from animal models to therapies. J Dent Res 88:894-903.
7. Grundmann O, Fillinger JL, Victory KR, Burd R, Limesand KH (2010). Restoration of radiation therapy-induced salivary gland dysfunction in mice by post therapy IGF-1 administration. BMC Cancer 10:417.
8. Jensen S, Pedersen A, Vissink A, Andersen E, Brown C, Davies A, et al. (2010). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 18:1039-1060.
9. Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH, et al. (2007). Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels. J Clin Endocrinol Metab 92:4820-4826. (Pubitemid 350223465)
10. Limesand KH, Barzen KA, Quissell DO, Anderson SM (2003). Synergistic suppression of apoptosis in salivary acinar cells by IGF1 and EGF. Cell Death Differ 10:345-355. (Pubitemid 36582372)
11. Limesand KH, Schwertfeger KL, Anderson SM (2006). MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells. Mol Cell Biol 26:8840-8856. (Pubitemid 44851943)
12. Limesand KH, Said S, Anderson SM (2009). Suppression of radiation-induced salivary gland dysfunction by IGF-1. PLoS ONE 4:e4663.
13. Limesand KH, Avila JL, Victory K, Chang HH, Shin YJ, Grundmann O, et al. (2010). IGF-1 preserves salivary gland function following fractionated radiation. Int J Radiat Oncol Biol Phys 78:579-586.
14. Mitchell GC, Fillinger JL, Sittadjody S, Avila JL, Burd R, Limesand KH (2010). IGF1 activates cell cycle arrest following irradiation by reducing binding of ΔNp63 to the p21 promoter. Cell Death Dis 2010:e50.
15. Osaki M, Oshimura M, Ito H (2004). PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9:667-676. (Pubitemid 40941196)
16. Palme CE, Gullane PJ, Gilbert RW (2004). Current treatment options in squamous cell carcinoma of the oral cavity. Surg Oncol Clin N Am 13:47-70. (Pubitemid 38328493)
17. Saikali Z, Setya H, Singh G, Persad S (2008). Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells. Cancer Cell Int 8:10.
18. Tosetti F, Vene R, Arena G, Morini M, Minghelli S, Noonan DM, et al. (2003). N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death. Mol Pharmacol 63:565-573. (Pubitemid 36297326)